Skip to content
Open·Ingested 90 days ago, not re-verified since

DoW Ovarian Cancer, Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Posted
May 4, 2026
Amount
$5,600,000
Closes
Oct 1, 2026 (in 59 days)

Get alerted when new grant funding like this opens.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
HT942526OCRPCTA
Assistance listing (CFDA)
12.420

Amount

$5,600,000

Who can apply

Open to all

About this opportunity

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

Refine this search